A European project aims to develop a system of small sensors worn on the body so that how well you walk, a vital sign of health and wellbeing, can be monitored and assessed during your daily routine.
Mobility - how well someone walks - is considered the ‘sixth vital sign’ of health. This is because poor gait, especially walking slowly, is associated with earlier death, greater risk of disease, cognitive decline, dementia and an increased risk of falls.
Funded by the European Innovative Medicines Initiative 2 Joint Undertaking, the project, called MOBILISE-D, aims to revolutionise assessment of mobility loss using digital technology to lead to enhanced clinical trials and better clinical management.
Clinicians and scientists from academic centres across Europe will collaborate with companies from the European Federation of Pharmaceutical Industries and Associations (EFPIA) - the goal is to develop, validate, and ensure regulation of better mobility outcomes.
The results of the project will directly lead to drug development and establish a roadmap for clinical implementation of new, complementary tools which will identify, categorize and monitor disability in patients. This will enable widespread, cost-effective access to managing conditions clinically through personalised healthcare.
To read the full article please visit the Newcastle University website